Preventing Illegal Laboratories and Protecting Public Health Act of 2024

This bill requires sellers of high-risk pathogens (like those that cause severe disease) to maintain detailed electronic logbooks tracking each sale. Sellers must record the agent name, quantity, purchaser details (with verified ID), intended use, and sale date, keeping records for five years. It also mandates regular federal reviews of high-containment laboratories to assess safety, oversight gaps, and national biosecurity needs, with reports to Congress. The law directly affects research labs, biotech companies, and other entities selling such pathogens, aiming to enhance public health protection through better documentation and facility oversight.